Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Evans

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Archives of Computational Methods in Engineering : State of the Art Reviews|January 23, 2023
A Review of Image-Based Simulation Applications in High-Value ManufacturingLlion Marc Evans, Emrah Sözümert, Bethany E Keenan, et al.
Advances in Therapy|August 22, 2014
Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trialsMarkolf Hanefeld, Rachele Berria, Jay Lin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 26, 2022
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 DiabetesIldiko Lingvay, Andrei-Mircea Catarig, Jack Lawson, et al.
Diabetes, Obesity & Metabolism|May 3, 2022
Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET)Marc Evans, Abhishek Shankar Chandramouli, Mads Faurby, et al.
Diabetes, Obesity & Metabolism|November 15, 2021
Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature reviewMarc Evans, Susanne Engberg, Mads Faurby, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 24, 2025
Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the FutureKevin Fernando, Derek Connolly, Eimear Darcy, et al.
European Endocrinology|April 11, 2018
Clinical Safety and Tolerability of Vildagliptin - Insights from Randomised Trials, Observational Studies and Post-marketing SurveillanceChantal Mathieu, Plamen Kozlovski, Päivi M Paldánius, et al.
Diabetes Care|July 2, 2008
Can admission and fasting glucose reliably identify undiagnosed diabetes in patients with acute coronary syndrome?Onyebuchi E Okosieme, Rajesh Peter, Muhammad Usman, et al.
Ecology of Food and Nutrition|May 29, 2012
Dietary goal attainment measures and psychosocial factors among Mexican Americans and non-Hispanic whites with type 2 diabetesKathaleen Briggs Early, Jill Armstrong Shultz, Marc Evans, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 15, 2017
Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes MellitusMarc Evans, Plamen Kozlovski, Päivi M Paldánius, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Archives of Computational Methods in Engineering : State of the Art Reviews|January 23, 2023
A Review of Image-Based Simulation Applications in High-Value ManufacturingLlion Marc Evans, Emrah Sözümert, Bethany E Keenan, et al.
Advances in Therapy|August 22, 2014
Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trialsMarkolf Hanefeld, Rachele Berria, Jay Lin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 26, 2022
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 DiabetesIldiko Lingvay, Andrei-Mircea Catarig, Jack Lawson, et al.
Diabetes, Obesity & Metabolism|May 3, 2022
Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET)Marc Evans, Abhishek Shankar Chandramouli, Mads Faurby, et al.
Diabetes, Obesity & Metabolism|November 15, 2021
Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature reviewMarc Evans, Susanne Engberg, Mads Faurby, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 24, 2025
Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the FutureKevin Fernando, Derek Connolly, Eimear Darcy, et al.
European Endocrinology|April 11, 2018
Clinical Safety and Tolerability of Vildagliptin - Insights from Randomised Trials, Observational Studies and Post-marketing SurveillanceChantal Mathieu, Plamen Kozlovski, Päivi M Paldánius, et al.
Diabetes Care|July 2, 2008
Can admission and fasting glucose reliably identify undiagnosed diabetes in patients with acute coronary syndrome?Onyebuchi E Okosieme, Rajesh Peter, Muhammad Usman, et al.
Ecology of Food and Nutrition|May 29, 2012
Dietary goal attainment measures and psychosocial factors among Mexican Americans and non-Hispanic whites with type 2 diabetesKathaleen Briggs Early, Jill Armstrong Shultz, Marc Evans, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 15, 2017
Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes MellitusMarc Evans, Plamen Kozlovski, Päivi M Paldánius, et al.
Pageof 16